PTSM: Pharmaceutical Technology Sourcing and Management-09-03-2008

CMC service providers are doing well, but clinical and preclinical CROs are doing even better.

The US Food and Drug Administration will hold a public meeting this month to gain public input on implementing the recommendations of the Nanotechnology Task Force report, taking another step closer to setting a regulatory framework for nanotechnology for pharmaceuticals and medical devices.

The pharmaceutical majors deploy green-chemistry strategies to improve the synthesis of active pharmaceutical ingredients and intermediates.